MLchartDataset catalogue

hyper-CVAD regimen

Term · Oncology and biomedicine · MLC-T-ONC-004060

An abbreviation for a chemotherapy combination used to treat some types of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Hyper-CVAD regimen includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. It also includes the drugs methotrexate and cytarabine. It is given as hyperfractionated therapy, in which the total dose of the drugs is divided into small doses and given more than once a day. Also called hyper-CVAD.

Table 1. Record
IdentifierMLC-T-ONC-004060
FieldOncology and biomedicine
Synonymshyper-CVAD
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-004060",
  "term": "hyper-CVAD regimen",
  "field": "Oncology and biomedicine",
  "definition": "An abbreviation for a chemotherapy combination used to treat some types of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Hyper-CVAD regimen includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. It also includes the drugs methotrexate and cytarabine. It is given as hyperfractionated therapy, in which the total dose of the drugs is divided into small doses and given more than once a day. Also called hyper-CVAD.",
  "synonyms": [
    "hyper-CVAD"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/hyper-cvad-regimen/"
}

Record 8,822 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.